Ownership history in Murchinson Ltd. · 9 quarters on record
This page tracks every 13F SEC filing in which Murchinson Ltd. reported a position in ORAMED PHARMACEUTICALS INC (ORMP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,340,247 | -411,312 | -23.5% | 0.61% | $3.8M | $2.66 |
| 2025 Q3 | UNCHANGED | 1,751,559 | — | 0% | 0.59% | $4.6M | $2.46 |
| 2025 Q2 | REDUCED | 1,751,559 | -200 | -0.0% | 1.40% | $3.9M | $2.10 |
| 2025 Q1 | ADDED | 1,751,759 | +800 | +0.0% | 0.20% | $3.7M | $2.00 |
| 2024 Q4 | ADDED | 1,750,959 | +42,080 | +2.5% | 1.81% | $4.2M | $2.26 |
| 2024 Q3 | ADDED | 1,708,879 | +833,887 | +95.3% | 1.13% | $4.2M | $2.27 |
| 2024 Q2 | REDUCED | 874,992 | -504,503 | -36.6% | 0.41% | $2.2M | $2.40 |
| 2024 Q1 | ADDED | 1,379,495 | +329,495 | +31.4% | 0.42% | $4.0M | $2.72 |
| 2023 Q4 | INITIATED | 1,050,000 | — | — | 0.42% | $2.4M | — |
As of 2025 Q4 — sorted by position size